A leading global centre in advanced pharmaceutical manufacturing research, housing a broad range of capabilities and expertise
About CMAC
Continuous Manufacturing and Advanced Crystallisation (CMAC) is a leading global centre in advanced pharmaceutical manufacturing research, housing a broad range of capabilities and expertise working in partnership with industrial collaborators since 2011.
CMAC's purpose is to transform current manufacturing processes into the medicine supply chain of the future. The ambitious research programme meets future needs of industry, consumers, and patients by developing state-of-the-art design and modelling methodologies and integrated, efficient production and supply chain systems. This enables fast development of customisable pharmaceutical and chemical products so they can be manufactured and supplied with consistent quality and controllable performance.
CMAC works with partners and collaborators ranging from multinational corporations to SMEs. To date, CMAC has published over 240 research publications in peer-reviewed journals.
The laboratory footprint is over 900 m2, and is designed to deliver a fully adaptable space for multi-phase batch and continuous primary processing. There's a dedicated, specialised support team to offer services and assistance to research activity and industrial projects. Also housed at CMAC are a number of analytical laboratories for advanced understanding of particulate formation & processing, and a secondary processing suite.